Related Experiment Video
Updated: Jun 13, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP
1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
The migration and invasion inhibitor protein (MIIP, also known as IIp45) was discovered as a negative regulator of cell migration and invasion in glioma. Our previous studies have shown that the MIIP protein was reduced or undetectable in some tissue samples obtained from patients with glioblastoma. The significance of MIIP in gliomagenesis is unknown. In this study, we report that MIIP has an important role in the inhibition of gliomagenesis and attenuation of mitotic transition. Increased MIIP expression levels inhibited colony formation and cell growth of glioma cell lines in vitro, whereas decreased expression by specific small interfering RNA for MIIP resulted in increased cell growth. Expression of MIIP in a glial-specific mouse model blocked glioma development and progression, thus showing that MIIP is an inhibitor of gliomagenesis. Furthermore, we show that MIIP attenuates mitotic transition and results in increased mitotic catastrophe. The biochemical mechanism of MIIP in this process is associated with its regulation of anaphase-promoting complex (APC/C) activity. MIIP interacts directly with Cdc20, and the interaction of MIIP with Cdc20 inhibits APC/C-mediated degradation of cyclin B1. Thus, MIIP attenuates mitotic transition and increases mitotic catastrophe, thereby inhibiting glioma development and progression.
Insights
The migration and invasion inhibitor protein (MIIP) suppresses glioma development by inhibiting cell growth and blocking tumor progression. MIIP also disrupts cell division, leading to increased cancer cell death.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The migration and invasion inhibitor protein (MIIP) is a known negative regulator of cell migration and invasion.
- Reduced MIIP expression is observed in glioblastoma patient samples, suggesting a potential role in gliomagenesis.
- The specific function of MIIP in glioma development remains largely unknown.
Purpose of the Study:
- To investigate the role of MIIP in gliomagenesis and its impact on mitotic transition.
- To elucidate the molecular mechanisms by which MIIP affects glioma progression.
Main Methods:
- In vitro studies using glioma cell lines to assess the effects of MIIP expression on cell growth and colony formation.
- In vivo studies using a glial-specific mouse model to evaluate MIIP's role in glioma development.
- Biochemical analyses to determine MIIP's interaction with cell cycle regulators, including Cdc20 and the anaphase-promoting complex (APC/C).
Main Results:
- Increased MIIP expression inhibited glioma cell growth and colony formation in vitro.
- Knockdown of MIIP using small interfering RNA led to increased glioma cell proliferation.
- MIIP expression in a mouse model blocked glioma development and progression.
- MIIP was found to attenuate mitotic transition, leading to increased mitotic catastrophe.
- MIIP directly interacts with Cdc20, inhibiting APC/C-mediated degradation of cyclin B1.
Conclusions:
- MIIP acts as a crucial inhibitor of gliomagenesis and progression.
- MIIP's mechanism involves the attenuation of mitotic transition through regulation of APC/C activity via Cdc20 interaction.
- MIIP's ability to induce mitotic catastrophe presents a potential therapeutic target for glioma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi
Inhibition of Cdk Activity
Drugs that Destabilize Microtubules

